JEWISH GENERAL HOSPITAL
Endometrial Cancer Biomarker Changes Following Exposure to Metformin
- First Posted Date
- 2014-01-23
- Last Posted Date
- 2016-08-30
- Lead Sponsor
- Jewish General Hospital
- Registration Number
- NCT02042495
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Study to Evaluate Resistance Mechanisms and Real-world Pharmacoeconomics of Crizotinib in NSCLC Patients
- Conditions
- First Posted Date
- 2014-01-22
- Last Posted Date
- 2017-08-30
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 29
- Registration Number
- NCT02041468
- Locations
- 🇨🇦
Centre hospitalier de l'Université de Montréal, Montreal, Quebec, Canada
🇨🇦Centre Hospitalier Universitaire de Sherbrooke, Sherbrooke, Quebec, Canada
🇨🇦Hôpital du Sacré-Coeur de Montréal, Montréal, Quebec, Canada
Focal Therapy Using HIFU for Localised Prostate Cancer
- First Posted Date
- 2013-12-19
- Last Posted Date
- 2017-04-19
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 25
- Registration Number
- NCT02016040
- Locations
- 🇨🇦
Jewish General Hospital,Urology Department, Montreal, Quebec, Canada
Developing and Implementing an Interdisciplinary Team-Based Care Approach (ITCA-ThyCa) for Thyroid Cancer Patients
- Conditions
- Interventions
- First Posted Date
- 2013-11-25
- Last Posted Date
- 2016-02-23
- Lead Sponsor
- Jewish General Hospital
- Registration Number
- NCT01994200
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Efficacy of a Combined Surgical and Pharmacological Therapy to Treat Mixed Urinary Incontinence.
- Conditions
- Interventions
- First Posted Date
- 2013-07-15
- Last Posted Date
- 2013-07-15
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 66
- Registration Number
- NCT01899794
AdVance® vs ARGUS® Sling Procedure in Male With Post Prostatectomy Stress Urinary Incontinence
- Conditions
- Interventions
- First Posted Date
- 2013-05-31
- Last Posted Date
- 2013-05-31
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 128
- Registration Number
- NCT01866085
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Frailty Assessment Before Cardiac Surgery & Transcatheter Interventions
- Conditions
- First Posted Date
- 2013-05-03
- Last Posted Date
- 2016-08-31
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 800
- Registration Number
- NCT01845207
- Locations
- 🇨🇦
St. Boniface Hospital, Winnipeg, Manitoba, Canada
🇺🇸Massachusetts General Hospital, Boston, Massachusetts, United States
🇨🇦Centre Hospitalier Universite de Montreal, Montreal, Quebec, Canada
Randomized Controlled Trial of the Meaning-Making Intervention (MMi)
- Conditions
- Interventions
- First Posted Date
- 2012-09-26
- Last Posted Date
- 2014-07-10
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 60
- Registration Number
- NCT01693991
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
🇨🇦McGill University Health Centre, Montreal, Quebec, Canada
Ipilimumab With Carboplatin and Paclitaxel in Patients With Unresectable Stage III and Stage IV Melanoma
- Conditions
- Interventions
- First Posted Date
- 2012-08-31
- Last Posted Date
- 2021-02-18
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 30
- Registration Number
- NCT01676649
- Locations
- 🇨🇦
Jewish General Hospital, Montreal, Quebec, Canada
Vitamin D Loading Dose in Advanced Lung Cancer
- First Posted Date
- 2012-06-29
- Last Posted Date
- 2017-08-18
- Lead Sponsor
- Jewish General Hospital
- Target Recruit Count
- 80
- Registration Number
- NCT01631526
- Locations
- 🇨🇦
Brojde Lung Cancer Centre, Jewish General Hospital, Montreal, Quebec, Canada